Has Sheldon Jordan received payments from drug or device companies?

Yes. Drug and device makers reported $3,139,202 in general payments to Sheldon Jordan across 1,429 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sheldon Jordan did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sheldon Jordan come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sheldon Jordan

Interventional Pain Medicine · Santa Monica, CANPI 1316941305

Payments from drug & device makers

$3,139,202in general payments, 2019–2025

Across 1,429 payments — averaging $2196.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Pfizer$3.1M
AbbVie$3K
CSL Behring$2K
Lundbeck LLC$2K
Teva Pharmaceuticals USA, Inc.$2K
Lilly USA, LLC$1K
plus $20K from 54 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Pfizer	37	$3,107,861
AbbVie(2 entities)	145	$3,276
CSL Behring	98	$1,817
Lundbeck LLC	73	$1,545
Teva Pharmaceuticals USA, Inc.	75	$1,522
Lilly USA, LLC	66	$1,375
Novartis	68	$1,168
AstraZeneca(2 entities)	41	$1,097
Merz Pharmaceuticals, LLC	33	$1,007
UCB, Inc.	48	$995
Amgen(2 entities)	41	$924
Genentech USA, Inc.	28	$763
Takeda Pharmaceuticals U.S.A., Inc.	34	$761
Jazz Pharmaceuticals Inc.	25	$734
Biogen	30	$672
Ipsen Biopharmaceuticals, Inc	35	$609
Harmony Biosciences LLC	20	$599
Argenx US, Inc.	23	$585
Merz North America, Inc.	20	$564
Eisai Inc.	18	$438
Upsher-smith Laboratories LLC	21	$433
Collegium Pharmaceutical, Inc.	26	$432
Otsuka America Pharmaceutical, Inc.	16	$406
Neurocrine Biosciences, Inc.	17	$392
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	16	$391
Revance Therapeutics, Inc.	6	$355
Axsome Therapeutics, Inc.	16	$346
Kyowa Kirin, Inc.	13	$339
MDD US Operations, LLC	24	$318
Tanabe Pharma America, Inc.	14	$292
Acadia Pharmaceuticals Inc	12	$280
TG Therapeutics, Inc.	8	$246
Biohaven Pharmaceutical Holding Company Ltd.	11	$237
Sunovion Pharmaceuticals Inc.	11	$225
Scilex Pharmaceuticals Inc.	10	$220
Abbott	9	$217
Stimwave Technologies Incorporated	3	$215
Biohaven Pharmaceuticals, Inc.	9	$215
Mallinckrodt Hospital Products Inc.	10	$214
Johnson & Johnson(2 entities)	8	$207
Avanos Medical	2	$205
E.r. Squibb & Sons, L.L.C.	11	$200
Bausch Health US, LLC	11	$196
EMD Serono, Inc.	8	$195
Sanofi	8	$192
Supernus Pharmaceuticals, Inc.	11	$188
Alnylam Pharmaceuticals Inc.	8	$186
Amneal Pharmaceuticals LLC	9	$176
GRT US Holding, Inc.	6	$156
Vertex	5	$143
Nevro Corp.	2	$131
Acorda Therapeutics, Inc	6	$131
Almatica Pharma LLC	6	$124
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	6	$121
SK Life Science, Inc.	5	$114
Biodelivery Sciences International, Inc.	7	$112
Zyla Life Sciences, Inc.	7	$112
Avanir Pharmaceuticals, Inc.	5	$112
Nalu Medical, Inc.	2	$104
Vanda Pharmaceuticals Inc.	3	$101

How this compares

$3,139,202 in reported general payments places this provider in the 95th percentile of 188 interventional pain medicine providers in California.

See all interventional pain medicine providers in California →

Other interventional pain medicine in Santa Monica

Ezekiel FinkBeverly Hills$2.3M
Matthew DotyOroville$1.3M
Tim LeierRancho Mirage$749K
Pragya GuptaEscondido$647K
Michael Verdolinla Mesa$563K
Standiford HelmOrange$476K
Patrick BuchananCamarillo$453K
Roy BrownlowSan Diego$452K
Andrew GermanovichRancho Mirage$408K
Jonathan GrossmanVisalia$404K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →